AE	Adverse event
ANC	Absolute neutrophil count
BC	Breast cancer
BMI	Body mass index
CI	Confidence interval
CMF	Cyclophosphamide, methotrexate and fluorouracil
CTC	Circulating tumor cells
DFS	Disease-free survival
Doc	Docetaxel
ER	Estrogen receptor
FEC	5-fluoroucacil, epirubicin and cyclophosphamide
5-FU	5-fluorouracil
G-CSF	Granulocyte-colony stimulating factor
Gem	Gemcitabine
HER2	Human epidermal growth factor receptor 2
HR	Hazard ratio
HRS	Hormone receptor status
MAPK	Mitogen-activated protein kinase
MUC1-C	Carboxy-terminal transmembrane subunit
MUC1-N	Amino-terminal extracellular subunit
NFκB	Nuclear factor kappa B
OS	Overall survival
PI3K	Phosphatidylinositol-3′-kinase
PR	Progesterone receptor
SGPT	Serum glutamate pyruvate transaminase